InventUM | University of Miami Miller School of Medicine

AI-based approach could make it easier to incorporate metabolic tumor volume into clinical trials and possibly patient care. Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a new, automated way to calculate metabolic tumor volume (MTV) in diffuse large B-cell lymphoma (DLBCL). These findings could make it much easier to calculate tumor volume for clinical trials and possibly patient care. The study was published in Cancers. “Metabolic tumor volume can have a profound impact on patient outcomes but, until now, there’s not been an automated way to calculate it,” said Juan Pablo Alderuccio, M.D., associate professor of medicine in the Division of Hematology and co-senior author on the study. “Now, we have developed an artificial intelligence-based system to get accurate tumor volumes both faster and with less human intervention.” Lymphoma patients with larger tumor volumes tend to have more challenging prognoses. As a result, clinicians have wanted to stratify patients based on MTV, but this has been quite difficult. Existing software is only semi-automated, meaning that radiologists have to pay close attention to the results and often fill in missing information, which can be a time-intensive process. “When we read a PET scan, there are both pathologic lesions and normal structures that light up,” said Russ Kuker, M.D., associate professor of radiology in the Division of Nuclear Medicine and first author on the study. “Radiologists review these images and differentiate between lesions and benign processes. Most software can’t tell the difference between something that is benign, or has normal physiologic activity, versus a tumor.” Faster, Better Readings. In the study, the researchers test drove a new, deep learning-based approach that fully automates MTV calculations. Dr. Kuker and colleagues used traditional, semi-automated methods to calculate MTV in 100 patients. Independently, medical physicist and co-senior author Fei Yang, Ph.D., in the Department of Radiation Oncology, reviewed the same scans using the deep learning algorithms. “We found the results were highly correlated,” said Dr. Alderuccio. “But even more importantly, instead of taking up to 30 minutes to come up with the answer for each scan, the machine learning approach took around five. By significantly decreasing the reading time, this opens the door to using MTV in clinical trials because you can use it on large numbers of patients and have the results right away.” This project was a multidisciplinary effort supported by Craig Moskowitz, M.D., Sylvester Comprehensive Cancer Center physician-in-chief, and initiated by Alan Pollack, M.D., Ph.D., who chairs the Department of Radiation Oncology. MTV could be a valuable tool for clinical trials, stratifying patients by risk to better understand who responds to treatment and why. In addition, this technique might be used to advance clinical care, though it will need considerably more validation. “We know that patients with higher MTV do worse,” said Dr. Alderuccio. “Those patients may be more likely to receive intensified or experimental therapies to improve outcomes. Patients with low metabolic tumor volume might present better outcomes to standard therapies. This machine learning approach could give us better opportunities to make those distinctions.”

International Study Shows Low Incidence of COVID Vaccine-Related Myocarditis, Higher Risk from Virus

Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis Patients

Miller School Researchers Find Clues for Potential ‘Long COVID’ Therapies

$3 Million Grant Awarded to Study Links between COVID and HIV

Dr. David DQ Zhang, M.D., Joins the Division of Colon and Rectal Surgery

Drs. Yasin Bez, Maria Hadjikyriakou, and Marisa Perera Join the Department of Psychiatry and Behavioral Sciences

Sylvester’s Sexual Health After Cancer Program Expands to Meet Needs of Women with Cancer

Drs. Liran Barda, Julie Grossman, and Kashyap Komarraju Tadisina Join the Department of Surgery

Gordon Center Director Named President-Elect of the Society for Simulation in Healthcare

Dr. Jennifer Coto Receives Mentored Translational Research Scholars Program Award

Study: New Brain Health Platform Gives Physicians New Tools to Precisely Assess Dementia Risk

Sylvester Researchers Receive $2M to Conduct Clinical Trial on Unique Immunotherapy

Gordon Center Director Named President-Elect of the Society for Simulation in Healthcare

Miller School Headlines at Learn Serve Lead 2022: The AAMC Annual Meeting

Miller School Launches Podcast Focused on Insights in Academic Medicine

Medical Student Completes NIH’s Medical Research Scholars Program

Sylvester Partners with Pan American Health Organization/World Health Organization and MD Anderson to Train Caribbean Clinicians in Mammography Quality Assurance

Dr. Pankaj Agrawal Is Appointed Chief of the Division of Neonatology

Gordon Center Director Named President-Elect of the Society for Simulation in Healthcare